Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data

Active, not recruitingOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

April 13, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Migraine Disorders
Interventions
DIAGNOSTIC_TEST

Diagnostic radiology

Clinical procedures include bone mineral measurement (bone densitometry, dxa) performed according to clinical practice; venipunctures for laboratory assessments (haematology and blood chemistry; bone turnover biomarkers P1NP and CTX).

Trial Locations (1)

6903

Chiara ZECCA, Lugano

All Listed Sponsors
lead

Ente Ospedaliero Cantonale, Bellinzona

OTHER